INTS vs TXN
Intensity Therapeutics, Inc. Common stock (INTS) versus Texas Instruments Incorporated (TXN) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Texas Instruments Incorporated (TXN) is a semiconductors company listed on NASDAQ.
INTS does not have a complete income-statement cache yet.
Latest reported TXN revenue for 2025-12-31 was $17.68B. Net income was $5.00B. Revenue was up 13.0% from 2024-12-31 to 2025-12-31. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
INTS currently screens at market cap $7.7M. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
Not investment advice. Open the INTS and TXN stock pages for the full models.
Not investment advice.